- Home
- ANTE vs QTTB Comparison
ANTE vs QTTB Comparison
Compare ANTE & QTTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANTE
- QTTB
- Stock Information
- Founded
- ANTE 2005
- QTTB 2015
- Country
- ANTE China
- QTTB United States
- Employees
- ANTE N/A
- QTTB N/A
- Industry
- ANTE Advertising
- QTTB Biotechnology: Pharmaceutical Preparations
- Sector
- ANTE Consumer Discretionary
- QTTB Health Care
- Exchange
- ANTE Nasdaq
- QTTB Nasdaq
- Market Cap
- ANTE 20.3M
- QTTB 18.9M
- IPO Year
- ANTE N/A
- QTTB N/A
- Fundamental
- Price
- ANTE $1.39
- QTTB $2.07
- Analyst Decision
- ANTE
- QTTB Hold
- Analyst Count
- ANTE 0
- QTTB 8
- Target Price
- ANTE N/A
- QTTB $24.00
- AVG Volume (30 Days)
- ANTE 114.8K
- QTTB 3.7M
- Earning Date
- ANTE 05-02-2025
- QTTB 08-07-2025
- Dividend Yield
- ANTE N/A
- QTTB N/A
- EPS Growth
- ANTE N/A
- QTTB N/A
- EPS
- ANTE N/A
- QTTB N/A
- Revenue
- ANTE $343,000.00
- QTTB N/A
- Revenue This Year
- ANTE N/A
- QTTB N/A
- Revenue Next Year
- ANTE N/A
- QTTB N/A
- P/E Ratio
- ANTE N/A
- QTTB N/A
- Revenue Growth
- ANTE N/A
- QTTB N/A
- 52 Week Low
- ANTE $0.26
- QTTB $1.35
- 52 Week High
- ANTE $2.90
- QTTB $53.79
- Technical
- Relative Strength Index (RSI)
- ANTE 75.28
- QTTB 50.42
- Support Level
- ANTE $0.94
- QTTB $2.02
- Resistance Level
- ANTE $1.50
- QTTB $2.40
- Average True Range (ATR)
- ANTE 0.14
- QTTB 0.35
- MACD
- ANTE 0.03
- QTTB -0.03
- Stochastic Oscillator
- ANTE 80.36
- QTTB 17.89
About ANTE AirNet Technology Inc.
AirNet Technology Inc provides in-flight solutions to connectivity, entertainment, and digital multimedia in China. It offers Internet connections through a network of satellites and land-based beacons, provides airline travelers with interactive entertainment, and breaking news, and furnishes corporate clients with advertisements tailored to the perceptions of the travelers. The revenues are mainly derived from selling advertising time slots on the companies advertising networks and cryptocurrency mining.
About QTTB Q32 Bio Inc. Common Stock
Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body's first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function. ADX-097, the lead product candidate from Q32's complement inhibitor platform, is a humanized anti-C3d monoclonal antibody fusion protein.